Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease…
CM Global Services (CMGS) Secures Exclusive Multi-Year Logistics & Procurement Partnerships with Compass Mining and NovoMod
DENVER, May 22, 2025 /PRNewswire/ -- CM Global Services LLC (CMGS) proudly announces…
First World Fair Play Day: Honouring the spirit of sportsmanship at the Olympic Games
19 May 2025 - The Olympic Games have always been about more than…
Hexaware Achieves AWS Data and Analytics Competency to Accelerate Data-driven Insights for Enterprises
MUMBAI, India, May 13, 2025 /PRNewswire/ -- Hexaware (NSE: HEXT), a leading…
DNV recognized as a Notified Body for Certification under In Vitro Diagnostic Regulation (IVDR)
OSLO, Norway, May 8, 2025 /PRNewswire/ -- DNV, the independent assurance and…
Sonata Software Achieves AWS DevOps Competency Status
BENGALURU, India and FREMONT, Calif., April 30, 2025 /PRNewswire/ -- Sonata Software…
Kia Telluride, EV9 Earn 2025 IIHS Top Safety Pick+ Awards
2025 Telluride maintains TSP+ status for the third consecutive year, meeting IIHS’s…
Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage…
MediBeacon Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published
Transdermal GFR System (TGFR) is a first-in-kind product for point of care…
Comanche Biopharma Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway (ILAP) Steering Group for CBP-4888, an Investigational siRNA Drug Candidate for the Treatment of sFlt1-mediated Preterm Preeclampsia
January 30, 2025 05:00 ET | Source: Comanche Biopharma ILAP aims to…